Capstone Investment Advisors (Netherlands)’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
OAG
Capstone Investment Advisors (Netherlands)'s ELV Position: Q2 2017 in Review
Capstone Investment Advisors (Netherlands) reduced its Elevance Health (ELV) stake by 26% in Q2 2017, selling an estimated $81.2K and leaving 1,277 shares worth $240K. The position accounts for 0.84% of the portfolio, ranked #44.
Capstone Investment Advisors (Netherlands) first reported a position in ELV in Q4 2016 and has held it in 3 quarters since. The position peaked at $320K in Q4 2016. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.
- Capstone Investment Advisors (Netherlands) held 1,277 shares of Elevance Health worth $240K as of Q2 2017.
- Capstone Investment Advisors (Netherlands) sold 452 Elevance Health shares in Q2 2017, an estimated $81.2K.
- Elevance Health made up 0.84% of Capstone Investment Advisors (Netherlands)'s portfolio in Q2 2017, its #44 holding.
- Capstone Investment Advisors (Netherlands) first reported a position in Elevance Health in Q4 2016 and has held it in 3 quarters since.
- Capstone Investment Advisors (Netherlands)'s Elevance Health position peaked at $320K in Q4 2016.
- 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.
Based on Capstone Investment Advisors (Netherlands)'s 13F filing for Q2 2017, filed 14 Aug 2017.